Sign up to save your podcasts
Or
Share Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained
How do the eligibility criteria for the monarchE and NATALEE clinical trials compare?
Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002403?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.3
2323 ratings
How do the eligibility criteria for the monarchE and NATALEE clinical trials compare?
Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002403?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
The Bob Harrington Show
13 Listeners
NEJM This Week
322 Listeners
Diabetes Core Update
106 Listeners
JACC This Week
170 Listeners
This Week in Cardiology
872 Listeners
JAMA Clinical Reviews
502 Listeners
AFP: American Family Physician Podcast
694 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
282 Listeners
Frankly Speaking About Family Medicine
255 Listeners
The Curbsiders Internal Medicine Podcast
3,333 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
135 Listeners
Core IM | Internal Medicine Podcast
1,111 Listeners
The Peter Attia Drive
8,023 Listeners
Annals On Call Podcast
195 Listeners
Medicine and the Machine
61 Listeners
Keeping Current
8 Listeners
Cardionerds: A Cardiology Podcast
424 Listeners
The Cribsiders
313 Listeners